Industry satellite symposium Industry Satellite Symposium

A Giant Leap in the Treatment Options for Advanced Bladder Cancer

Lecture Time
13:20 - 13:40
Speakers
  • Yohann Loriot
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
09.12.2017
Time
13:00 - 14:00
Authors
  • Yohann Loriot
Designing immune oncology clinical trials: Opportunities and hurdles Educational session

Response, progress and survival as endpoints for immuno-oncology therapy trials

Lecture Time
16:15 - 16:35
Speakers
  • Naiyer Rizvi
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
08.12.2017
Time
16:15 - 18:05
Authors
  • Naiyer Rizvi
What’s new in breast & gynaecological cancers Educational session

LECTURE MOVED to Sunday Room C at 10:20 - Defining the immunogram for patients with breast cancer

Lecture Time
16:55 - 16:55
Speakers
  • Giuseppe Curigliano
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
09.12.2017
Time
16:15 - 17:45
Authors
  • Giuseppe Curigliano
Combination of radiotherapy and immunocheckpoint inhibitors Educational session

Kick the immune system with immunocytokines

Lecture Time
11:20 - 11:40
Speakers
  • Dario Neri
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
08.12.2017
Time
11:00 - 12:30
Authors
  • Dario Neri
Vaccines in the primary or secondary prevention setting Educational session

Generating type I immunity to oncogenic proteins

Lecture Time
15:15 - 15:35
Speakers
  • Nora Disis
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
09.12.2017
Time
14:15 - 15:45
Authors
  • Nora Disis
Combining immune checkpoint inhibitors and VEGF targeted therapies in cancer treatment Proffered Paper Session

Invited Discussant LBA1_PR

Lecture Time
18:50 - 19:05
Speakers
  • Solange Peters
  • Naiyer Rizvi
Session Name
Combining immune checkpoint inhibitors and VEGF targeted therapies in cancer treatment
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
07.12.2017
Time
18:15 - 19:15
Authors
  • Solange Peters
  • Naiyer Rizvi
PDL1 and other protein immunohistochemistry Educational session

PDL1 expression as a predictive and prognostic factor

Lecture Time
16:50 - 17:10
Speakers
  • Keith Kerr
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
07.12.2017
Time
16:30 - 18:00
Authors
  • Keith Kerr
What’s new in genitourinary (GU) tumours Educational session

Can we replace first line targeted therapy with immune therapy in renal cancer?

Lecture Time
09:50 - 10:10
Speakers
  • Laurence Albiges
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
09.12.2017
Time
09:10 - 10:40
Authors
  • Laurence Albiges
What’s new in brain tumours Educational session

Lessons from immunotherapy in animal models of glioma

Lecture Time
11:00 - 11:20
Speakers
  • Serena Pellegatta
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
10.12.2017
Time
11:00 - 12:30
Authors
  • Serena Pellegatta
Keynote lecture: ESMO Award for Immuno Oncology Keynote Lecture

Introducing the gut microbiome into the complexity of anticancer immunosurveillance

Lecture Time
13:45 - 14:15
Speakers
  • Laurence Zitvogel
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
07.12.2017
Time
13:45 - 14:15
Authors
  • Laurence Zitvogel
Innovative biomarkers and immune profiling Educational session

Biomarker development to integrate immune effector and suppressor responses in cancer

Lecture Time
16:15 - 16:35
Speakers
  • Lisa Butterfield
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
08.12.2017
Time
16:15 - 17:45
Authors
  • Lisa Butterfield
What’s new in gastrointestinal (GI) cancers Educational session

Why are MSI-high tumours so immunogenic?

Lecture Time
09:20 - 09:40
Speakers
  • Matthias Kloor
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
10.12.2017
Time
09:00 - 10:30
Authors
  • Matthias Kloor